Home > Riviste > Minerva Biotecnologica > Fascicoli precedenti > Minerva Biotecnologica 2018 September;30(3) > Minerva Biotecnologica 2018 September;30(3):75-81

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW   

Minerva Biotecnologica 2018 September;30(3):75-81

DOI: 10.23736/S1120-4826.18.02404-7

Copyright © 2018 EDIZIONI MINERVA MEDICA

lingua: Inglese

Basic and clinical aspects of resistin

Chiara ROSSO 1 *, Gian P. CAVIGLIA 1, Sharmila FAGOONEE 2, Elisabetta BUGIANESI 1, Giorgio M. SARACCO 1

1 Division of Gastroenterology and Hepatology, Department of Medical Sciences, University of Turin, Turin, Italy; 2 Institute for Biostructures and Bioimages (CNR) c/o Molecular Biotechnology Center, Turin, Italy


PDF


Resistin is a peptide hormone belonging to the class of cysteine-rich secreted proteins involved in the modulation of inflammation and immunity, particularly in insulin-resistant states. Circulating levels of resistin are elevated in obesity, diabetes and other chronic inflammatory conditions such as inflammatory bowel disease. However, the pathogenic role of resistin in the onset and progression of these diseases is not completely understood and the partial homology of resistin in animal models compared to humans limits our understanding of its physiological role. This review aims to summarize the main mechanisms linking resistin to inflammation as well as its clinical significance in different chronic liver and gastrointestinal diseases.


KEY WORDS: Resistin - Adipokines - Inflammation

inizio pagina